Dr. Glynn brings decades of experience in metabolic health, nutrition and supplement innovation to support Tranont’s mission to impact 1 billion lives
Tranont announces the newest member of its Scientific Advisory Board, Dr. Erin Glynn—a renowned expert in metabolic health, nutrition and product development with over 20 years of experience in academia and the dietary supplement industry.
In her role on the Scientific Advisory Board, Glynn will work closely with Tranont’s leadership and product teams to guide innovation, oversee scientific product development and provide educational support to Tranont associates. With a passion for simplifying complex science, Glynn aims to empower Tranont’s field leaders with tools and training that make sharing product benefits easier and more impactful.
Glynn’s appointment emphasizes Tranont’s focus on women’s health and strengthens representation and expertise in this area. She will play a prominent, forward-facing role—shaping and communicating Tranont’s mission to simplify women’s health with effective, science-backed products that integrate seamlessly into daily life. Glynn will develop solutions that help women feel and perform at their best every day.
“I’m thrilled and honored to join the Tranont family as part of the Scientific Advisory Board,” said Glynn. “What truly drew me to Tranont was the company’s uniqueness, quality formulations and mission to impact 1 billion lives for good. From transformative products like DHS to women’s health formulations such as Tranont For Her and the new Creatine formula, it’s clear that Tranont is committed to creating solutions that improve people’s lives.”
Glynn holds a bachelor’s degree in exercise physiology from Texas A&M University and a doctorate in preventive medicine and community health from the University of Texas Medical Branch. She furthered her expertise through a postdoctoral fellowship at Duke University’s Stedman Nutrition & Metabolism Center, focusing on advanced metabolic research and clinical application. Throughout her career, Glynn has authored more than 30 peer-reviewed research publications and presented her work at leading scientific conferences nationwide.
After more than a decade in academic research, Glynn transitioned into the nutraceutical industry, where she has led research and development teams and developed clinically supported products for multi-million-dollar brands. Her approach blends science with a deep passion for wellness, product innovation and education.
“Dr. Glynn’s expertise in metabolic and gut health will be instrumental in driving future product innovations, particularly in underserved areas like women’s health,” said Russell Losee, Co-Founder and COO at Tranont. “Her holistic approach aligns perfectly with Tranont’s commitment to developing life-changing health products and providing associates with the resources they need to succeed.”
To learn more about Tranont and its growing Scientific Advisory Board, visit www.tranont.com/about/scientific-advisory-board.
About Tranont
Tranont changes lives through achievable, science-driven solutions that simplify wellness. With clinically validated ingredients and research-backed formulations, our products are designed to make holistic health simple, effective, and seamlessly fit into your daily routine, so you can feel and perform at your best every day.
Tranont is a movement focused on improving women’s health, building wealth, and providing service within communities, powered by science and made for real life. By joining Tranont as an associate, you can transform lives with our products while building personal wealth and reaching your financial and lifestyle goals. Tranont is on a mission to change lives and inspire meaningful, lasting transformations.
Discover more about improving your health, creating more wealth and leaving a lasting impact by visiting www.tranont.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429511976/en/
Contacts
Mark Fredrickson
SnappConner PR
801-806-0161
mark@snappconner.com
